More pre-natals recalled

[Guest guest]

Ther-Rx Corporation, a subsidiary of KV Pharmaceutical Company is issuing a

voluntary nationwide recall of prescription prenatal and iron supplement

nutritionals as identified below (all lots within their expiration dates) at

a wholesale level. The Company is taking this action as a precautionary

measure, because the products may have been manufactured under conditions

that did not sufficiently comply with current Good Manufacturing Practice

(cGMP).

Patients who may have these products in their possession should continue to

take them in accordance with their prescriptions, as the risk of suddenly

stopping needed medication may place patients at risk. Patients should

contact their physician or healthcare provider if they have experienced any

problems that may be related to taking or using these products, or to obtain

replacement medications or prescriptions.

*Products Recalled to the Wholesale Level:*

*Prescription Iron Supplement Products:*

Chromagen® Caplet

Chromagen® FA Caplet

Chromagen® Forte Caplet

Encora® Capsule

Niferex® Gold Tablet

Niferex® 150 Forte Capsule

Repliva 21/7® Tablet

*Prescription Prenatal Vitamin Products:*

PreCare® Chewable Tablet

PreCare® Conceive Tablet

PreCare Premier® Tablet

PremesisRx® Tablet

PrimaCare® Capsule/Tablet

PrimaCare® Advantage™ Capsule/Tablet

PrimaCare® ONE Capsule

Any retail customer inquiries related to this action should be addressed to

Ther-Rx Customer Service at **, or faxed to Ther-Rx Customer

Service at **, or e-mailed to *info@...*

*. *Representatives are available Monday through Friday, 8 am to 5 pm CST.

Ther-Rx Corporation has initiated recall notifications to wholesalers

nationwide who received any inventory of the recalled products, with

instructions for returning the recalled products. Patients with questions

about the recall should call the telephone number above, or contact their

healthcare providers.

This recall is being conducted with the knowledge of the U.S. Food and Drug

Administration (FDA). At this time, the Company is unable to determine when

distribution of these products will resume.

Any adverse reactions experienced with the use of these products should also

be reported to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by fax

at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville,

MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.

The recall announcement is posted on www.kvpharmaceutical.com.;

--

Ortiz, MS RD

" Nutrition is a Science,

Not an Opinion Survey "